NURECA
Nureca Limited (NURECA) Stock Analysis
Nureca Limited is an Indian consumer health and wellness products company marketing devices and personal care under brands such as Dr. Trust. It sells blood pressure monitors, thermometers, and home health products through e-commerce and retail. The business targets affordable at-home diagnostics and wellness. It is listed on Indian stock exchanges and distributes primarily in India.
Healthcare › Medical Devices
₹339.00
+1.88% 1W | +44.30% 52W
Market Cap
339 CR
P/E Ratio
75.3
52W High
₹358
52W Low
₹204
Div. Yield
0%
Beta
0.6
50 DMA
₹317.4
200 DMA
₹279.8
Profit Margin
2.8%
Inst. Own.
0%
🔥 APPROACHING RESISTANCE
🔥 APPROACHING RESISTANCE
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.23 | 31.35 | 22.37 | 16.97 | 20.27 | 31.19 | 26.46 | 31.74 | 34.18 | 37.74 | 39.64 | 35.41 | 40.34 |
| Expenses | 24.13 | 29.97 | 26.62 | 21.40 | 22.63 | 33.54 | 30.47 | 30.54 | 34.74 | 34.47 | 36.39 | 41.19 | 36.92 |
| Operating Profit | -2.90 | 1.38 | -4.25 | -4.43 | -2.36 | -2.35 | -4.01 | 1.20 | -0.56 | 3.27 | 3.25 | -5.78 | 3.42 |
| OPM % | -13.66% | 4.40% | -19.00% | -26.10% | -11.64% | -7.53% | -15.15% | 3.78% | -1.64% | 8.66% | 8.20% | -16.32% | 8.48% |
| Other Income | 2.67 | 3.20 | 5.90 | -1.26 | 5.79 | 3.17 | 1.48 | 1.99 | 2.57 | 2.32 | 2.19 | 1.02 | 1.82 |
| Interest | 0.12 | 0.08 | 0.11 | 0.18 | 0.15 | 0.27 | 0.18 | 0.62 | 0.25 | 0.46 | 0.28 | 0.30 | 0.20 |
| Depreciation | 0.58 | 0.59 | 0.59 | 0.60 | 0.66 | 0.62 | 0.54 | 0.52 | 0.53 | 0.54 | 0.50 | 0.45 | 0.61 |
| Profit before tax | -0.93 | 3.91 | 0.95 | -6.47 | 2.62 | -0.07 | -3.25 | 2.05 | 1.23 | 4.59 | 4.66 | -5.51 | 4.43 |
| Tax % | -23.66% | 25.83% | 82.11% | -35.86% | 36.64% | 585.71% | -13.85% | -20.00% | 34.15% | 21.13% | 19.96% | 10.71% | 30.93% |
| Net Profit | -0.71 | 2.89 | 0.17 | -4.15 | 1.66 | -0.48 | -2.80 | 2.47 | 0.81 | 3.63 | 3.73 | -6.09 | 3.07 |
| EPS in Rs | -0.71 | 2.89 | 0.17 | -4.15 | 1.66 | -0.48 | -2.80 | 2.47 | 0.81 | 3.63 | 3.91 | -6.38 | 3.22 |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 62 | 99 | 213 | 256 | 111 | 92 | 110 | 147 | 153 |
| Expenses | 53 | 90 | 152 | 200 | 126 | 102 | 117 | 147 | 149 |
| Operating Profit | 9 | 10 | 62 | 56 | -15 | -10 | -8 | 0 | 4 |
| OPM % | 15% | 10% | 29% | 22% | -13% | -11% | -7% | 0.1% | 2.7% |
| Other Income | 0 | 0 | 3 | 8 | 7 | 11 | 12 | 8 | 7 |
| Interest | 0 | 1 | 2 | 1 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 9 | 9 | 62 | 61 | -11 | -3 | 1 | 5 | 8 |
| Tax % | 30% | 26% | 26% | 26% | -23% | -30% | 37% | 58% | |
| Net Profit | 6 | 6 | 46 | 45 | -8 | -2 | 1 | 2 | 4 |
| EPS in Rs | 6,230.00 | 6,400.00 | 46.37 | 44.96 | -8.25 | -1.79 | 0.85 | 2.18 | 4.38 |
| Dividend Payout % | 0% | 0% | 4% | 7% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 10.0% | -7.0% | – |
| Profit CAGR | 30.0% | -46.0% | – |
Shareholding Pattern
Promoters64.33%
FIIs0.07%
DIIs0.04%
Public35.56%
Promoters64.97%
FIIs0.07%
DIIs0.04%
Public34.92%
Promoters64.97%
FIIs0.08%
DIIs0.04%
Public34.91%
Promoters68.09%
FIIs0.28%
DIIs0.24%
Public31.39%
Promoters68.09%
FIIs0.11%
DIIs0.24%
Public31.57%
Promoters62.98%
FIIs0.10%
Public36.91%
Promoters63.24%
FIIs0.07%
Public36.69%
Promoters64.30%
FIIs1.07%
DIIs0.04%
Public34.59%
Promoters68.09%
FIIs0.28%
DIIs0.24%
Public31.39%
Promoters68.09%
FIIs0.11%
DIIs0.24%
Public31.57%
NURECA
Holdings Analysis
Key strengths & risk signals
62
Overall
43
Fundamental
81
Technical
Risks (1)
Cannot calculate PEG - insufficient growth data.
Strengths (4)
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
BULLISH TREND! 50-day average (317.4) is above 200-day average (279.8) - positive signal.
GOOD YEAR! Stock gained 44.3% in the last year.
STRONG! Trading at 87.7% of 52W range - near yearly highs.
Fundamental & Technical Analysis
62Overall
43Fundamental
81Technical
Fundamental Breakdown
Growth Quality
10/30
Revenue CAGR: 9.7% (MODERATE, 8/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 2.8% profit margin - thin profits.
PEG Valuation
0/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.03 - excellent financial health.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 36.92% public ownership - moderate retail influence.
Stability Index
8/10
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (317.4) is above 200-day average (279.8) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (339.0) is above both moving averages.
Trend Pattern
10/20
AT RESISTANCE! Stock is at key resistance level.
52W Performance
10/10
GOOD YEAR! Stock gained 44.3% in the last year.
Volume Sentiment
25/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 16,085 vs down days: 12,155. Ratio: 1.32x
RSI
3/5
NEUTRAL! RSI at 55.0 - balanced momentum.
52W Range
5/5
STRONG! Trading at 87.7% of 52W range - near yearly highs.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - 1.9% (1 week), -0.4% (1 month), 43.2% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
Peer Comparison
Healthcare · Medical Devices · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NURECA | ₹339.00 | 75.3 | 2.8% | 9.7% | – | +44.3% | 62 | APPROACHING RESISTANCE | +287.5% | -150.8% | +17.8% | +13.8% |
| UNIVPHOTO | ₹599.10 | – | -91.2% | -24.3% | – | +124.7% | 67 | BREAKOUT | -366.5% | -445.8% | +10.0% | +19.6% |
| FISCHER | ₹32.80 | 72.9 | 8.2% | 1,097.9% | – | -70.6% | 57 | BREAKDOWN | -22.4% | -153.5% | +250.0% | -16.2% |
| AAREYDRUGS | ₹102.00 | 79.1 | 0.9% | 4.5% | 1.7% | +28.8% | 64 | BREAKOUT | -28.6% | -37.5% | -56.4% | -76.5% |
| LYKALABS | ₹85.00 | – | -6.6% | 13.3% | – | -16.4% | 59 | CONSOLIDATING UP | +133.3% | -127.6% | +28.2% | +51.1% |
| AMBALALSA | ₹38.70 | 21.9 | 6.6% | 5.8% | 15.9% | +19.9% | 66 | BREAKDOWN | -51.2% | -38.5% | -7.2% | -33.4% |
| MEDICO | ₹34.00 | 20.5 | 5.8% | 13.8% | 21.9% | -19.3% | 59 | BREAKDOWN | +38.9% | -57.6% | +81.2% | +22.2% |
| MEDICAMEQ | ₹320.00 | 44 | 4.7% | 12.0% | -13.4% | +1.2% | 61 | BREAKOUT | -4.5% | -46.2% | +11.4% | -21.0% |
Data from TradeAlone · Updated daily
